Masimo Corporation
NASDAQ: MASI · HEALTHCARE · MEDICAL DEVICES
Updated 2026-04-29
Masimo Corporation (MASI) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for MASI.
Valued
Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.
MASI historical valuation range
Where current P/E sits in MASI's own 5Y range.
MASI intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
MASI valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 46.47x
P/S Ratio — History
Current: 6.12x
Is MASI overvalued in 2026?
Masimo Corporation (MASI) currently trades at $178.46 per share with a market capitalization of $9,344,667,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 53/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 46.5x, below its 5-year median of 55.2x. The PEG ratio of 4.83 indicates the price has run ahead of the underlying growth rate.
Looking at its own history, MASI is currently trading cheaper than 80% of the last 5Y on P/E. This places it in the 20th percentile of its historical range, a level that has historically coincided with attractive entry points.
Our discounted cash flow model estimates MASI's intrinsic value at $157.54 per share, against the current market price of $178.46. This implies a margin of safety of +14.28%. The stock is priced close to its estimated fair value, offering limited upside without further operational improvement.
The Piotroski F-Score of 5/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: MASI trades at a fair valuation on our framework, with a Smart Value Score of 53/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.
Frequently asked questions
Is MASI overvalued in 2026?
Based on a Smart Value Score of 53/100, MASI is fairly valued. Price reasonably reflects current fundamentals with limited cushion in either direction.
What is MASI's fair value?
Our DCF model estimates MASI's intrinsic value at $157.54 per share, versus the current price of $178.46. This produces a margin of safety of +14.28%.
What P/E ratio does MASI trade at?
MASI trades at a P/E of 46.5x on trailing twelve-month earnings, compared to its 5-year median of 55.2x.
Is MASI a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 53/100 reflects the combined read on growth, quality, and price. The profile is balanced. Best suited for investors with an existing thesis.
How does MASI's valuation compare to its history?
On P/E, MASI currently sits in the 20th percentile of its own 5Y range. That is historically cheap relative to where it has traded over the period.
What is MASI's Smart Value Score?
MASI's Smart Value Score is 53/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.